Published: 01-08-2016
Review
The Association between ANXA11 Gene Polymorphisms and Sarcoidosis: a Meta-Analysis and systematic review
Abstract 52 | PDF Downloads 41Page 102-111
An epidemiological perspective of the pathology and etiology of sarcoidosis
Abstract 45 | PDF Downloads 52Page 112-116
Original Articles: Clinical Research
High-resolution CT predictors of hypersensitivity pneumonitis
Abstract 46 | PDF Downloads 89Page 117-123
Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids
Abstract 67 | PDF Downloads 154Page 124-129
Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases
Abstract 65 | PDF Downloads 87Page 130-138
Serum fibroblastic growth factor 23 in acute Sarcoidosis and normal kidney function
Abstract 73 | PDF Downloads 34Page 139-142
Platelet aggregability in patients with interstitial pneumonias
Abstract 49 | PDF Downloads 49Page 143-150
Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis
Abstract 118 | PDF Downloads 75Page 151-156
Exercise related ventilation dynamics and clinical correlates in patients with fibrotic idiopathic interstitial pneumonias
Abstract 71 | PDF Downloads 55Page 157-165
Case Reports
Polishing surgical metal pieces, granulomatosis and mineralogical analysis
Abstract 65 | PDF Downloads 39Page 166-170
Pulmonary metastases from low grade sarcoma in a patient with pulmonary sarcoidosis. Sarcoidosis or sarcoid-like reaction?
Abstract 49 | PDF Downloads 62Page 171-174
Cardiac sarcoidosis – silent destroyer.
Abstract 38 | PDF Downloads 47Page 175-177
Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy
Abstract 66 | PDF Downloads 32Page 178-181
Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension
Abstract 72 | PDF Downloads 35Page 182-185
Successful management of acute respiratory failure in an Idiopathic Pulmonary Fibrosis patient using an extracorporeal carbon dioxide removal system
Abstract 67 | PDF Downloads 67Page 186-190
Letter to Editor
Repositioning ‘old’ drugs to treat rare diseases: arguing from the mechanism of action
Abstract 80 | PDF Downloads 42Page 191-194